Jeff Randall
Director of Finance/CFO chez YM Biosciences USA, Inc.
Fortune : - $ au 31/03/2024
Profil
Lorin Jeffry Randall currently works at Point 5 Technologies, Inc., as Director and YM Biosciences USA, Inc., as Chief Financial Officer.
Mr. Randall also formerly worked at Nanosphere, Inc., as Chairman from 2011 to 2016, Quad Systems Corp., as Director, Acorda Therapeutics, Inc., as Independent Director from 2009 to 2023, Tengion, Inc., as Independent Director from 2011 to 2014, Rapid Micro Biosystems, Inc., as Director, Motologic, Inc., as Director, Opexa Therapeutics, Inc., as Director from 2007 to 2009, Athersys, Inc., as Independent Director from 2007 to 2022, Aurinia Pharmaceuticals, Inc., as Lead Independent Director from 2016 to 2019, i-STAT Corp., as Chief Financial Officer & Senior Vice President from 2002 to 2004, CFM Technologies, Inc., as Chief Financial Officer & Vice President from 1995 to 2001, Eximias Pharmaceutical Corp., as Chief Financial Officer & Senior Vice President from 2004 to 2006, and Greenwich Pharmaceuticals, Inc., as Chief Financial Officer & Vice President.
Mr. Randall received his Masters Business Admin degree from Northeastern University and undergraduate degree from The Pennsylvania State University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 24/04/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Jeff Randall
| Sociétés | Poste | Début |
|---|---|---|
| Point 5 Technologies, Inc. | Director/Board Member | - |
YM Biosciences USA, Inc.
 YM Biosciences USA, Inc. Pharmaceuticals: MajorHealth Technology YM Biosciences USA, Inc. develops and commercializes pharmaceutical products. The company was founded on November 23, 2005 and is headquartered in Wayne, PA. | Director of Finance/CFO | - |
Anciens postes connus de Jeff Randall
| Sociétés | Poste | Fin |
|---|---|---|
| ACORDA THERAPEUTICS, INC. | Chairman | 20/07/2009 |
| ATHERSYS, INC. | Director/Board Member | 16/06/2022 |
| AURINIA PHARMACEUTICALS INC. | Director/Board Member | 26/06/2019 |
| NANOSPHERE, INC. | Chairman | 01/01/2016 |
| TENGION, INC. | Director/Board Member | 01/01/2014 |
Formation de Jeff Randall
| Northeastern University | Masters Business Admin |
| The Pennsylvania State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| ACORDA THERAPEUTICS, INC. | Health Technology |
| TENGION, INC. | Health Technology |
| RAPID MICRO BIOSYSTEMS, INC. | Producer Manufacturing |
| ATHERSYS, INC. | Health Technology |
| AURINIA PHARMACEUTICALS INC. | Health Technology |
| Entreprise privées | 10 |
|---|---|
i-STAT Corp.
 i-STAT Corp. Medical SpecialtiesHealth Technology i-STAT Corp. is used to develope, manufacture and market medical diagnostic products for blood analysis that provide healthcare professionals critical diagnostic information accurately and immediately at the point of patient care. Founded in 1983 by Imants Lauks, i-STAT was headquartered in East Windsor, NJ. | Health Technology |
Quad Systems Corp.
 Quad Systems Corp. Computer PeripheralsElectronic Technology Quad Systems Corp. engages in the distribution, marketing, design, manufacture and support of surface mount technology equipment used in the assembly of printed circuit wiring boards. The company was founded by David H. Young and is headquartered in Willow Gove, PA. | Electronic Technology |
CFM Technologies, Inc.
 CFM Technologies, Inc. SemiconductorsElectronic Technology CFM Technologies, Inc. designs, manufactures, and markets advanced wet processing equipment for sale to the worldwide semiconductor industry. The private company is based in Exton, PA. CFM Technologies was acquired by Mattson Technology, Inc., a SUB of Beijing Economic & Technology Development Area from Evonik Steag GmbH on January 03, 2001 for $45.29 million. The company is ultimately controlled by the Beijing Economic & Technology Development Area. The company was founded in 1984 by Roger A. Carolin, Huw Kenton Thomas, Christopher Frank McConnell. | Electronic Technology |
Eximias Pharmaceutical Corp.
 Eximias Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Eximias Pharmaceutical Corp. develops pharmaceuticals for treatment of cancer disorders. It offers its services in the mid-Atlantic areas. The company is headquartered in Berwyn, PA. | Health Technology |
Nanosphere, Inc.
 Nanosphere, Inc. Medical SpecialtiesHealth Technology Nanosphere, Inc. engages in the development, manufacture, and market of molecular diagnostics platform. Its platform, Verigene System, enables clinicians to identify and treat bacteria and viruses responsible for some of the most complex, costly, and deadly infectious diseases. The company was founded by Chad A. Mirkin and Robert Letsinger on December 30, 1999 and is headquartered in Northbrook, IL. | Health Technology |
| Motologic, Inc. | |
Greenwich Pharmaceuticals, Inc.
 Greenwich Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Greenwich Pharmaceuticals, Inc. is an American company that specializes in commercial physical research. | Commercial Services |
Opexa Therapeutics, Inc.
 Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | Health Technology |
| Point 5 Technologies, Inc. | |
YM Biosciences USA, Inc.
YM Biosciences USA, Inc. Pharmaceuticals: MajorHealth Technology YM Biosciences USA, Inc. develops and commercializes pharmaceutical products. The company was founded on November 23, 2005 and is headquartered in Wayne, PA. | Health Technology |
